POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C8L_A_CFFA940_1 (PROTEIN (GLYCOGEN PHOSPHORYLASE))	1zef	ALKALINE PHOSPHATASE (Homo sapiens)	4 / 6	ASN A  84 PHE A 107 ALA A  94 GLY A  93	None PHE  A 802 (-4.4A) None SEP  A  92 ( 2.4A)	1.03A	20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C8L_A_CFFA940_1 (PROTEIN (GLYCOGEN PHOSPHORYLASE))	2r3v	MEVALONATE KINASE (Homo sapiens)	4 / 6	ASN A 205 PHE A 190 ALA A 189 GLY A 192	None	1.13A	19.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1C8L_A_CFFA940_1 (PROTEIN (GLYCOGEN PHOSPHORYLASE))	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.78A	80.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C8L_A_CFFA940_1 (PROTEIN (GLYCOGEN PHOSPHORYLASE))	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.08A	21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C8L_A_CFFA940_1 (PROTEIN (GLYCOGEN PHOSPHORYLASE))	5fn4	NICASTRIN (Homo sapiens)	4 / 6	PHE A 448 HIS A 449 ALA A 442 GLY A 366	None	1.08A	21.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C8L_A_CFFA940_1 (PROTEIN (GLYCOGEN PHOSPHORYLASE))	5fur	TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 6 (Homo sapiens)	4 / 6	HIS J 422 ALA J 378 GLY J 375 TYR J 374	None	1.13A	22.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1C8L_A_CFFA940_1 (PROTEIN (GLYCOGEN PHOSPHORYLASE))	5ikp	GLYCOGEN PHOSPHORYLASE, BRAIN FORM (Homo sapiens)	4 / 6	HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.72A	83.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GFZ_A_CFFA940_1 (GLYCOGEN PHOSPHORYLASE)	1zef	ALKALINE PHOSPHATASE (Homo sapiens)	4 / 6	ASN A  84 PHE A 107 ALA A  94 GLY A  93	None PHE  A 802 (-4.4A) None SEP  A  92 ( 2.4A)	1.04A	20.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1GFZ_A_CFFA940_1 (GLYCOGEN PHOSPHORYLASE)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.81A	80.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GFZ_A_CFFA940_1 (GLYCOGEN PHOSPHORYLASE)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.09A	18.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GFZ_A_CFFA940_1 (GLYCOGEN PHOSPHORYLASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.06A	21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GFZ_A_CFFA940_1 (GLYCOGEN PHOSPHORYLASE)	5fn4	NICASTRIN (Homo sapiens)	4 / 6	PHE A 448 HIS A 449 ALA A 442 GLY A 366	None	1.06A	21.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1GFZ_A_CFFA940_1 (GLYCOGEN PHOSPHORYLASE)	5ikp	GLYCOGEN PHOSPHORYLASE, BRAIN FORM (Homo sapiens)	4 / 6	HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.76A	83.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	1zef	ALKALINE PHOSPHATASE (Homo sapiens)	4 / 6	ASN A  84 PHE A 107 ALA A  94 GLY A  93	None PHE  A 802 (-4.4A) None SEP  A  92 ( 2.4A)	0.98A	21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L5Q_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	5 / 6	ASN A 282 PHE A 285 ALA A 610 GLY A 612 TYR A 613	None	0.29A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L5Q_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	5 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612	None	0.84A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.10A	18.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.06A	22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5fn4	NICASTRIN (Homo sapiens)	4 / 6	PHE A 448 HIS A 449 ALA A 442 GLY A 366	None	1.04A	22.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L5Q_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5ikp	GLYCOGEN PHOSPHORYLASE, BRAIN FORM (Homo sapiens)	4 / 6	HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.84A	81.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L5Q_A_CFFA864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	4 / 4	TRP A 174 HIS A 614 LYS A 617 MET A 618	None	0.22A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	1zef	ALKALINE PHOSPHATASE (Homo sapiens)	4 / 6	ASN A  84 PHE A 107 ALA A  94 GLY A  93	None PHE  A 802 (-4.4A) None SEP  A  92 ( 2.4A)	0.98A	21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L5Q_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	5 / 6	ASN A 282 PHE A 285 ALA A 610 GLY A 612 TYR A 613	None	0.35A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L5Q_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	5 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612	None	0.84A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	4mob	ACYL-COENZYME A THIOESTERASE 12 (Homo sapiens)	4 / 6	ASN A 252 PHE A 285 ALA A 317 GLY A 316	ADP  A 402 (-2.9A) ADP  A 402 (-4.8A) None None	1.14A	17.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	4uis	GAMMA-SECRETASE (Homo sapiens)	4 / 6	PHE A 448 HIS A 449 ALA A 442 GLY A 366	None	1.13A	19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.04A	22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5fn4	NICASTRIN (Homo sapiens)	4 / 6	PHE A 448 HIS A 449 ALA A 442 GLY A 366	None	1.04A	22.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L5Q_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5ikp	GLYCOGEN PHOSPHORYLASE, BRAIN FORM (Homo sapiens)	4 / 6	HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.84A	81.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_B_CFFB1864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2pfr	ARYLAMINE N-ACETYLTRANSFERASE 2 (Homo sapiens)	3 / 3	TRP A  67 HIS A  43 MET A  42	None	1.26A	16.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_B_CFFB1864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3b13	DEDICATOR OF CYTOKINESIS PROTEIN 2 (Homo sapiens)	3 / 3	TRP A1481 HIS A1231 MET A1201	None	1.13A	18.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L5Q_B_CFFB1864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	3 / 3	TRP A 174 HIS A 614 MET A 618	None	0.27A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_B_CFFB1864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ff6	ACETYL-COA CARBOXYLASE 2 (Homo sapiens)	3 / 3	TRP A2078 HIS A1993 MET A2075	None	1.07A	21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_B_CFFB1864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	4asi	ACETYL-COA CARBOXYLASE 1 (Homo sapiens)	3 / 3	TRP A2004 HIS A1919 MET A2001	None	1.09A	22.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_B_CFFB1864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5zbh	NEUROPEPTIDE Y RECEPTOR TYPE 1,T4 LYSOZYME,NEUROPEPTID E Y RECEPTOR TYPE 1 (Escherichia virus T4; Homo sapiens)	3 / 3	TRP A 276 HIS A 306 MET A 310	None	0.85A	7.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_B_CFFB1864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5zbq	NEUROPEPTIDE Y RECEPTOR TYPE 1,T4 LYSOZYME (Escherichia virus T4; Homo sapiens)	3 / 3	TRP A 276 HIS A 306 MET A 310	None	1.04A	6.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	1zef	ALKALINE PHOSPHATASE (Homo sapiens)	4 / 6	ASN A  84 PHE A 107 ALA A  94 GLY A  93	None PHE  A 802 (-4.4A) None SEP  A  92 ( 2.4A)	0.99A	21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L7X_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	5 / 6	ASN A 282 PHE A 285 ALA A 610 GLY A 612 TYR A 613	None	0.35A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L7X_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	5 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612	None	0.89A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.06A	18.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	4mob	ACYL-COENZYME A THIOESTERASE 12 (Homo sapiens)	4 / 6	ASN A 252 PHE A 285 ALA A 317 GLY A 316	ADP  A 402 (-2.9A) ADP  A 402 (-4.8A) None None	1.14A	17.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.03A	22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5fn4	NICASTRIN (Homo sapiens)	4 / 6	PHE A 448 HIS A 449 ALA A 442 GLY A 366	None	1.05A	22.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L7X_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5ikp	GLYCOGEN PHOSPHORYLASE, BRAIN FORM (Homo sapiens)	4 / 6	HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.87A	81.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_A_CFFA864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	1x6g	MEGAKARYOCYTE-ASSOCI ATED TYROSINE-PROTEIN KINASE (Homo sapiens)	3 / 3	TRP A  53 HIS A  26 LYS A  30	None	1.45A	7.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_A_CFFA864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	1xnj	BIFUNCTIONAL 3'-PHOSPHOADENOSINE 5'-PHOSPHOSULFATE SYNTHETASE 1 (Homo sapiens)	3 / 3	TRP B 457 HIS B 363 LYS B 367	None	1.30A	22.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_A_CFFA864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2qjf	BIFUNCTIONAL 3'-PHOSPHOADENOSINE 5'-PHOSPHOSULFATE SYNTHETASE 1 (Homo sapiens)	3 / 3	TRP A 457 HIS A 363 LYS A 367	None	1.08A	20.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L7X_A_CFFA864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	3 / 3	TRP A 174 HIS A 614 LYS A 617	None	0.25A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_A_CFFA864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	4b99	MITOGEN-ACTIVATED PROTEIN KINASE 7 (Homo sapiens)	3 / 3	TRP A 226 HIS A 145 LYS A 184	None	1.33A	18.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_A_CFFA864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	4rws	C-X-C CHEMOKINE RECEPTOR TYPE 4/ENDOLYSIN CHIMERIC PROTEIN (Escherichia virus T4; Homo sapiens)	3 / 3	TRP A 102 HIS A 113 LYS A 110	None	1.42A	19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_A_CFFA864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	4wjg	HAPTOGLOBIN (Homo sapiens)	3 / 3	TRP C 280 HIS C 291 LYS C 293	None	1.41A	15.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_A_CFFA864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	4zrq	CD320 ANTIGEN TRANSCOBALAMIN-2 (Homo sapiens)	3 / 3	TRP C  72 HIS A  56 LYS A  59	None	1.48A	8.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_A_CFFA864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	4zsl	MITOGEN-ACTIVATED PROTEIN KINASE 7 (Homo sapiens)	3 / 3	TRP A 226 HIS A 145 LYS A 184	GOL  A 406 (-3.7A) None None	1.36A	16.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L7X_A_CFFA864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5ikp	GLYCOGEN PHOSPHORYLASE, BRAIN FORM (Homo sapiens)	3 / 3	TRP A 174 HIS A 614 LYS A 617	None	0.44A	81.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_A_CFFA864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5ixd	TYROSINE-PROTEIN KINASE JAK1 (Homo sapiens)	3 / 3	TRP A 116 HIS A 264 LYS A 267	None	1.48A	20.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	1zef	ALKALINE PHOSPHATASE (Homo sapiens)	4 / 6	ASN A  84 PHE A 107 ALA A  94 GLY A  93	None PHE  A 802 (-4.4A) None SEP  A  92 ( 2.4A)	1.03A	21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L7X_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	5 / 6	ASN A 282 PHE A 285 ALA A 610 GLY A 612 TYR A 613	None	0.39A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L7X_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	5 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612	None	0.90A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.09A	18.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	4mob	ACYL-COENZYME A THIOESTERASE 12 (Homo sapiens)	4 / 6	ASN A 252 PHE A 285 ALA A 317 GLY A 316	ADP  A 402 (-2.9A) ADP  A 402 (-4.8A) None None	1.13A	17.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.05A	22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5fn4	NICASTRIN (Homo sapiens)	4 / 6	PHE A 448 HIS A 449 ALA A 442 GLY A 366	None	1.04A	22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1433_1 (CHITINASE)	5l0v	PROTEIN O-GLUCOSYLTRANSFERAS E 1 (Homo sapiens)	4 / 5	TRP A 164 TYR A 161 ASP A 133 PHE A 104	None	1.20A	20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	1i71	APOLIPOPROTEIN(A) (Homo sapiens)	3 / 3	TRP A  32 THR A  36 TYR A  39	None	0.84A	8.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	1l1f	GLUTAMATE DEHYDROGENASE 1 (Homo sapiens)	3 / 3	TRP A 182 THR A 175 TYR A  99	None	0.70A	19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	2a5j	RAS-RELATED PROTEIN RAB-2B (Homo sapiens)	3 / 3	TRP A 105 THR A  67 TYR A  80	None	1.02A	17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	2jgz	G2/MITOTIC-SPECIFIC CYCLIN-B1 (Homo sapiens)	3 / 3	TRP B 208 THR B 276 TYR B 277	None	0.80A	21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	2k60	PROTEIN (STROMAL INTERACTION MOLECULE 1) (Homo sapiens)	3 / 3	TRP A 132 THR A 143 TYR A 144	None	1.29A	16.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	2mqi	TYROSINE-PROTEIN KINASE FYN (Homo sapiens)	3 / 3	TRP A 149 THR A 223 TYR A 213	None	1.18A	12.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	2n1b	GTP-BINDING NUCLEAR PROTEIN RAN (Homo sapiens)	3 / 3	TRP A 104 THR A  66 TYR A  79	None	1.19A	19.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	2o52	RAS-RELATED PROTEIN RAB-4B (Homo sapiens)	3 / 3	TRP A 102 THR A  64 TYR A  77	None	1.01A	18.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	2xyd	ANGIOTENSIN-CONVERTI NG ENZYME (Homo sapiens)	3 / 3	TRP A 198 THR A 179 TYR A 175	None	1.23A	23.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	3f5x	CYCLIN-A2 (Homo sapiens)	3 / 3	TRP B 217 THR B 285 TYR B 286	None	0.71A	22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	3kv4	PHD FINGER PROTEIN 8 (Homo sapiens)	3 / 3	TRP A 282 THR A  82 TYR A 243	None	1.22A	21.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	3nbh	RECQ-MEDIATED GENOME INSTABILITY PROTEIN 1 RECQ-MEDIATED GENOME INSTABILITY PROTEIN 2 (Homo sapiens)	3 / 3	TRP B  59 THR A 538 TYR A 493	None	1.24A	17.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	4bvw	APOLIPOPROTEIN(A) (Homo sapiens)	3 / 3	TRP A  32 THR A  36 TYR A  39	None	0.89A	9.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	4lnp	SORBIN AND SH3 DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	3 / 3	TRP A 830 THR A 845 TYR A 846	None	1.27A	10.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	5f5r	HEAT SHOCK PROTEIN 75 KDA, MITOCHONDRIAL (Homo sapiens)	3 / 3	TRP A 231 THR A  94 TYR A 206	None	1.29A	21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	5fuc	INTERLEUKIN-6 RECEPTOR SUBUNIT ALPHA, INTERLEUKIN-6 RECEPTOR (Homo sapiens)	3 / 3	TRP C 264 THR C 247 TYR C 238	None	1.29A	17.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	5mpo	MOLYBDOPTERIN SYNTHASE SULFUR CARRIER SUBUNIT (Homo sapiens)	3 / 3	TRP A  38 THR A  19 TYR A  11	None	1.29A	15.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	5vem	ECTONUCLEOTIDE PYROPHOSPHATASE/PHOS PHODIESTERASE FAMILY MEMBER 5 (Homo sapiens)	3 / 3	TRP A 124 THR A  81 TYR A  77	None	1.16A	20.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1434_1 (CHITINASE)	5wp6	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY M MEMBER 4 (Homo sapiens)	3 / 3	TRP A 152 THR A 107 TYR A 103	None	1.00A	12.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_A_CFFA1435_1 (CHITINASE)	1hjv	CHITINASE-3 LIKE PROTEIN 1 (Homo sapiens)	7 / 11	TYR A  27 PHE A  58 GLY A  98 MET A 204 TYR A 206 ASP A 207 TRP A 352	NAG  A  -1 (-3.8A) NAG  A  -2 (-4.7A) NAG  A  -2 ( 4.2A) NAG  A   1 (-3.7A) NAG  A  -1 (-4.6A) NAG  A  -1 (-3.7A) NAG  A  -1 (-3.5A)	0.66A	30.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_A_CFFA1435_1 (CHITINASE)	1hkk	CHITOTRIOSIDASE-1 (Homo sapiens)	8 / 11	TYR A  27 PHE A  58 GLY A  98 MET A 210 TYR A 212 ASP A 213 TYR A 267 TRP A 358	AMI  A1388 (-3.6A) AMI  A1388 (-4.8A) AMI  A1388 ( 3.7A) AMI  A1388 (-3.3A) AMI  A1388 (-4.8A) AMI  A1388 ( 2.9A) NAA  A1387 (-3.6A) AMI  A1388 (-3.5A)	0.74A	30.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_A_CFFA1435_1 (CHITINASE)	1wb0	CHITOTRIOSIDASE 1 (Homo sapiens)	7 / 11	PHE A  58 GLY A  98 ASP A 138 MET A 210 TYR A 212 TYR A 267 TRP A 360	None	0.84A	30.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_A_CFFA1435_1 (CHITINASE)	1wb0	CHITOTRIOSIDASE 1 (Homo sapiens)	7 / 11	TYR A  27 PHE A  58 GLY A  98 GLU A 140 MET A 210 TYR A 212 TRP A 360	None	0.82A	30.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_A_CFFA1435_1 (CHITINASE)	1wb0	CHITOTRIOSIDASE 1 (Homo sapiens)	8 / 11	TYR A  27 PHE A  58 GLY A  98 MET A 210 TYR A 212 ASP A 213 TYR A 267 TRP A 360	None	0.56A	30.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_A_CFFA1435_1 (CHITINASE)	2ybu	ACIDIC MAMMALIAN CHITINASE (Homo sapiens)	7 / 11	PHE A  58 GLY A  98 ASP A 138 MET A 210 TYR A 212 TYR A 267 TRP A 360	CX9  A1398 (-4.5A) CX9  A1398 (-3.5A) CX9  A1398 (-3.0A) CX9  A1398 (-3.3A) CX9  A1398 (-4.3A) None CX9  A1398 ( 3.3A)	0.84A	31.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_A_CFFA1435_1 (CHITINASE)	2ybu	ACIDIC MAMMALIAN CHITINASE (Homo sapiens)	7 / 11	TYR A  27 PHE A  58 GLY A  98 GLU A 140 MET A 210 TYR A 212 TRP A 360	None CX9  A1398 (-4.5A) CX9  A1398 (-3.5A) CX9  A1398 (-3.7A) CX9  A1398 (-3.3A) CX9  A1398 (-4.3A) CX9  A1398 ( 3.3A)	0.84A	31.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_A_CFFA1435_1 (CHITINASE)	2ybu	ACIDIC MAMMALIAN CHITINASE (Homo sapiens)	8 / 11	TYR A  27 PHE A  58 GLY A  98 MET A 210 TYR A 212 ASP A 213 TYR A 267 TRP A 360	None CX9  A1398 (-4.5A) CX9  A1398 (-3.5A) CX9  A1398 (-3.3A) CX9  A1398 (-4.3A) CX9  A1398 ( 4.4A) None CX9  A1398 ( 3.3A)	0.51A	31.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_B_CFFB2434_1 (CHITINASE)	1bhg	BETA-GLUCURONIDASE (Homo sapiens)	4 / 6	GLU A 352 TYR A 388 ASP A 369 PHE A 589	None	1.36A	23.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_B_CFFB2434_1 (CHITINASE)	1w45	ANNEXIN A8 (Homo sapiens)	4 / 6	GLU A  28 ASP A  26 PHE A  21 ARG A  51	None	1.19A	21.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_B_CFFB2434_1 (CHITINASE)	3n9u	CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR SUBUNIT 7 (Homo sapiens)	4 / 6	GLU C 153 ASP C 156 PHE C 168 ARG C 158	None	1.38A	16.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_B_CFFB2434_1 (CHITINASE)	3py7	MALTOSE-BINDING PERIPLASMIC PROTEIN,PAXILLIN LD1,PROTEIN E6 CHIMERA (Deltapapillomavi rus 4; Escherichia coli; Homo sapiens)	4 / 6	GLU A 311 TYR A 308 ASP A 315 ARG A 317	None	1.46A	20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_B_CFFB2434_1 (CHITINASE)	4mzv	EPITHELIAL CELL ADHESION MOLECULE (Homo sapiens)	4 / 6	GLU A 223 ASP A 219 PHE A 226 ARG A 173	None None None DMU  A 301 (-4.0A)	1.46A	17.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_B_CFFB2434_1 (CHITINASE)	5fqd	DNA DAMAGE-BINDING PROTEIN 1 (Homo sapiens)	4 / 6	GLU A1095 ASP A1090 PHE A 998 ARG A1074	None	1.23A	19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_B_CFFB2434_1 (CHITINASE)	5tj2	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,GASDERMIN-B FUSION PROTEIN (Escherichia coli; Homo sapiens)	4 / 6	GLU A 310 TYR A 307 ASP A 314 ARG A 316	None	1.48A	21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_B_CFFB2434_1 (CHITINASE)	5vcs	ALPHA-1,6-MANNOSYL-G LYCOPROTEIN 2-BETA-N-ACETYLGLUCO SAMINYLTRANSFERASE (Homo sapiens)	4 / 6	TYR A 443 ASP A 436 PHE A 188 ARG A 223	None	1.14A	12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_B_CFFB2434_1 (CHITINASE)	6cnj	NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT BETA-2 (Homo sapiens)	4 / 6	GLU B 133 ASP B 140 PHE B 137 ARG B 207	None	1.48A	11.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_B_CFFB2435_1 (CHITINASE)	1hjv	CHITINASE-3 LIKE PROTEIN 1 (Homo sapiens)	6 / 10	PHE A  58 GLY A  98 MET A 204 TYR A 206 ASP A 207 TRP A 352	NAG  A  -2 (-4.7A) NAG  A  -2 ( 4.2A) NAG  A   1 (-3.7A) NAG  A  -1 (-4.6A) NAG  A  -1 (-3.7A) NAG  A  -1 (-3.5A)	0.51A	30.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_B_CFFB2435_1 (CHITINASE)	1hkk	CHITOTRIOSIDASE-1 (Homo sapiens)	6 / 10	PHE A  58 ASP A 138 GLU A 140 MET A 210 TYR A 212 TRP A 358	AMI  A1388 (-4.8A) AMI  A1388 (-3.1A) AMI  A1388 ( 3.3A) AMI  A1388 (-3.3A) AMI  A1388 (-4.8A) AMI  A1388 (-3.5A)	1.10A	30.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_B_CFFB2435_1 (CHITINASE)	1hkk	CHITOTRIOSIDASE-1 (Homo sapiens)	6 / 10	PHE A  58 ASP A 138 MET A 210 TYR A 212 TYR A 267 TRP A 358	AMI  A1388 (-4.8A) AMI  A1388 (-3.1A) AMI  A1388 (-3.3A) AMI  A1388 (-4.8A) NAA  A1387 (-3.6A) AMI  A1388 (-3.5A)	0.97A	30.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_B_CFFB2435_1 (CHITINASE)	1hkk	CHITOTRIOSIDASE-1 (Homo sapiens)	6 / 10	PHE A  58 GLY A  98 GLU A 140 MET A 210 TYR A 212 TRP A 358	AMI  A1388 (-4.8A) AMI  A1388 ( 3.7A) AMI  A1388 ( 3.3A) AMI  A1388 (-3.3A) AMI  A1388 (-4.8A) AMI  A1388 (-3.5A)	0.78A	30.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_B_CFFB2435_1 (CHITINASE)	1hkk	CHITOTRIOSIDASE-1 (Homo sapiens)	7 / 10	PHE A  58 GLY A  98 MET A 210 TYR A 212 ASP A 213 TYR A 267 TRP A 358	AMI  A1388 (-4.8A) AMI  A1388 ( 3.7A) AMI  A1388 (-3.3A) AMI  A1388 (-4.8A) AMI  A1388 ( 2.9A) NAA  A1387 (-3.6A) AMI  A1388 (-3.5A)	0.48A	30.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_B_CFFB2435_1 (CHITINASE)	1wb0	CHITOTRIOSIDASE 1 (Homo sapiens)	7 / 10	PHE A  58 GLY A  98 ASP A 138 GLU A 140 MET A 210 TYR A 212 TRP A 360	None	0.98A	30.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_B_CFFB2435_1 (CHITINASE)	1wb0	CHITOTRIOSIDASE 1 (Homo sapiens)	7 / 10	PHE A  58 GLY A  98 ASP A 138 MET A 210 TYR A 212 TYR A 267 TRP A 360	None	0.81A	30.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_B_CFFB2435_1 (CHITINASE)	1wb0	CHITOTRIOSIDASE 1 (Homo sapiens)	7 / 10	PHE A  58 GLY A  98 MET A 210 TYR A 212 ASP A 213 TYR A 267 TRP A 360	None	0.37A	30.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_B_CFFB2435_1 (CHITINASE)	2ybu	ACIDIC MAMMALIAN CHITINASE (Homo sapiens)	7 / 10	PHE A  58 GLY A  98 ASP A 138 GLU A 140 MET A 210 TYR A 212 TRP A 360	CX9  A1398 (-4.5A) CX9  A1398 (-3.5A) CX9  A1398 (-3.0A) CX9  A1398 (-3.7A) CX9  A1398 (-3.3A) CX9  A1398 (-4.3A) CX9  A1398 ( 3.3A)	1.01A	31.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_B_CFFB2435_1 (CHITINASE)	2ybu	ACIDIC MAMMALIAN CHITINASE (Homo sapiens)	7 / 10	PHE A  58 GLY A  98 ASP A 138 MET A 210 TYR A 212 TYR A 267 TRP A 360	CX9  A1398 (-4.5A) CX9  A1398 (-3.5A) CX9  A1398 (-3.0A) CX9  A1398 (-3.3A) CX9  A1398 (-4.3A) None CX9  A1398 ( 3.3A)	0.81A	31.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2A3B_B_CFFB2435_1 (CHITINASE)	2ybu	ACIDIC MAMMALIAN CHITINASE (Homo sapiens)	7 / 10	PHE A  58 GLY A  98 MET A 210 TYR A 212 ASP A 213 TYR A 267 TRP A 360	CX9  A1398 (-4.5A) CX9  A1398 (-3.5A) CX9  A1398 (-3.3A) CX9  A1398 (-4.3A) CX9  A1398 ( 4.4A) None CX9  A1398 ( 3.3A)	0.32A	31.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_B_CFFB2435_1 (CHITINASE)	4ay1	CHITINASE-3-LIKE PROTEIN 2 (Homo sapiens)	5 / 10	PHE A  63 GLY A 103 ASP A 213 TYR A 269 TRP A 360	None NAG  A 401 (-3.5A) NAG  A 401 (-2.8A) NAG  A 400 (-3.7A) NAG  A 401 (-3.7A)	0.59A	28.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DD1_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	1zef	ALKALINE PHOSPHATASE (Homo sapiens)	4 / 6	ASN A  84 PHE A 107 ALA A  94 GLY A  93	None PHE  A 802 (-4.4A) None SEP  A  92 ( 2.4A)	1.01A	21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DD1_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.86A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DD1_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.12A	18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DD1_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	4uis	GAMMA-SECRETASE (Homo sapiens)	4 / 6	PHE A 448 HIS A 449 ALA A 442 GLY A 366	None	1.13A	19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DD1_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.07A	22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DD1_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5fn4	NICASTRIN (Homo sapiens)	4 / 6	PHE A 448 HIS A 449 ALA A 442 GLY A 366	None	1.03A	22.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DD1_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5ikp	GLYCOGEN PHOSPHORYLASE, BRAIN FORM (Homo sapiens)	4 / 6	HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.77A	81.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DD1_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	1zef	ALKALINE PHOSPHATASE (Homo sapiens)	4 / 6	ASN A  84 PHE A 107 ALA A  94 GLY A  93	None PHE  A 802 (-4.4A) None SEP  A  92 ( 2.4A)	1.02A	21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DD1_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.86A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DD1_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.09A	18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DD1_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.06A	22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DD1_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5fn4	NICASTRIN (Homo sapiens)	4 / 6	PHE A 448 HIS A 449 ALA A 442 GLY A 366	None	1.07A	22.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DD1_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5ikp	GLYCOGEN PHOSPHORYLASE, BRAIN FORM (Homo sapiens)	4 / 6	HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.81A	81.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DD1_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5syt	CAAX PRENYL PROTEASE 1 HOMOLOG (Homo sapiens)	4 / 6	PHE A 108 ALA A 112 GLY A 110 TYR A 111	None	1.14A	21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_A_CFFA904_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	1zef	ALKALINE PHOSPHATASE (Homo sapiens)	4 / 6	ASN A  84 PHE A 107 ALA A  94 GLY A  93	None PHE  A 802 (-4.4A) None SEP  A  92 ( 2.4A)	1.00A	21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DDS_A_CFFA904_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.88A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_A_CFFA904_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.11A	18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_A_CFFA904_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	4uis	GAMMA-SECRETASE (Homo sapiens)	4 / 6	PHE A 448 HIS A 449 ALA A 442 GLY A 366	None	1.12A	19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_A_CFFA904_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.06A	22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_A_CFFA904_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5fn4	NICASTRIN (Homo sapiens)	4 / 6	PHE A 448 HIS A 449 ALA A 442 GLY A 366	None	1.03A	22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_A_CFFA904_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5fur	TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 6 (Homo sapiens)	4 / 6	HIS J 422 ALA J 378 GLY J 375 TYR J 374	None	1.14A	20.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DDS_A_CFFA904_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5ikp	GLYCOGEN PHOSPHORYLASE, BRAIN FORM (Homo sapiens)	4 / 6	HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.82A	81.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	1zef	ALKALINE PHOSPHATASE (Homo sapiens)	4 / 6	ASN A  84 PHE A 107 ALA A  94 GLY A  93	None PHE  A 802 (-4.4A) None SEP  A  92 ( 2.4A)	1.00A	21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DDS_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.87A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.09A	18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	4mob	ACYL-COENZYME A THIOESTERASE 12 (Homo sapiens)	4 / 6	ASN A 252 PHE A 285 ALA A 317 GLY A 316	ADP  A 402 (-2.9A) ADP  A 402 (-4.8A) None None	1.13A	17.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	4uis	GAMMA-SECRETASE (Homo sapiens)	4 / 6	PHE A 448 HIS A 449 ALA A 442 GLY A 366	None	1.14A	19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.04A	22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5fn4	NICASTRIN (Homo sapiens)	4 / 6	PHE A 448 HIS A 449 ALA A 442 GLY A 366	None	1.04A	22.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DDS_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5ikp	GLYCOGEN PHOSPHORYLASE, BRAIN FORM (Homo sapiens)	4 / 6	HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.79A	81.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDW_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	1zef	ALKALINE PHOSPHATASE (Homo sapiens)	4 / 6	ASN A  84 PHE A 107 ALA A  94 GLY A  93	None PHE  A 802 (-4.4A) None SEP  A  92 ( 2.4A)	0.99A	21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DDW_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.88A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDW_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.12A	18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDW_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	4uis	GAMMA-SECRETASE (Homo sapiens)	4 / 6	PHE A 448 HIS A 449 ALA A 442 GLY A 366	None	1.12A	19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDW_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.08A	22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDW_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5fn4	NICASTRIN (Homo sapiens)	4 / 6	PHE A 448 HIS A 449 ALA A 442 GLY A 366	None	1.02A	22.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DDW_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5ikp	GLYCOGEN PHOSPHORYLASE, BRAIN FORM (Homo sapiens)	4 / 6	HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.83A	81.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDW_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	1zef	ALKALINE PHOSPHATASE (Homo sapiens)	4 / 6	ASN A  84 PHE A 107 ALA A  94 GLY A  93	None PHE  A 802 (-4.4A) None SEP  A  92 ( 2.4A)	1.00A	21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DDW_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.89A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDW_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.11A	18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDW_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	4uis	GAMMA-SECRETASE (Homo sapiens)	4 / 6	PHE A 448 HIS A 449 ALA A 442 GLY A 366	None	1.15A	19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDW_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.06A	22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDW_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5fn4	NICASTRIN (Homo sapiens)	4 / 6	PHE A 448 HIS A 449 ALA A 442 GLY A 366	None	1.05A	22.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DDW_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5ikp	GLYCOGEN PHOSPHORYLASE, BRAIN FORM (Homo sapiens)	4 / 6	HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.82A	81.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G6M_A_CFFA1_1 (CHITINASE)	1hjv	CHITINASE-3 LIKE PROTEIN 1 (Homo sapiens)	7 / 11	PHE A  58 GLY A  98 TRP A  99 MET A 204 TYR A 206 ASP A 207 TRP A 352	NAG  A  -2 (-4.7A) NAG  A  -2 ( 4.2A) NAG  A   1 (-3.6A) NAG  A   1 (-3.7A) NAG  A  -1 (-4.6A) NAG  A  -1 (-3.7A) NAG  A  -1 (-3.5A)	0.73A	30.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G6M_A_CFFA1_1 (CHITINASE)	1hjv	CHITINASE-3 LIKE PROTEIN 1 (Homo sapiens)	7 / 11	TYR A  27 PHE A  58 GLY A  98 MET A 204 TYR A 206 ASP A 207 TRP A 352	NAG  A  -1 (-3.8A) NAG  A  -2 (-4.7A) NAG  A  -2 ( 4.2A) NAG  A   1 (-3.7A) NAG  A  -1 (-4.6A) NAG  A  -1 (-3.7A) NAG  A  -1 (-3.5A)	0.74A	30.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G6M_A_CFFA1_1 (CHITINASE)	1hkk	CHITOTRIOSIDASE-1 (Homo sapiens)	9 / 11	PHE A  58 GLY A  98 TRP A  99 GLU A 140 MET A 210 TYR A 212 ASP A 213 TYR A 267 TRP A 358	AMI  A1388 (-4.8A) AMI  A1388 ( 3.7A) NAA  A1390 ( 4.3A) AMI  A1388 ( 3.3A) AMI  A1388 (-3.3A) AMI  A1388 (-4.8A) AMI  A1388 ( 2.9A) NAA  A1387 (-3.6A) AMI  A1388 (-3.5A)	0.72A	33.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G6M_A_CFFA1_1 (CHITINASE)	1hkk	CHITOTRIOSIDASE-1 (Homo sapiens)	9 / 11	TYR A  27 PHE A  58 GLY A  98 GLU A 140 MET A 210 TYR A 212 ASP A 213 TYR A 267 TRP A 358	AMI  A1388 (-3.6A) AMI  A1388 (-4.8A) AMI  A1388 ( 3.7A) AMI  A1388 ( 3.3A) AMI  A1388 (-3.3A) AMI  A1388 (-4.8A) AMI  A1388 ( 2.9A) NAA  A1387 (-3.6A) AMI  A1388 (-3.5A)	0.79A	33.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G6M_A_CFFA1_1 (CHITINASE)	1wb0	CHITOTRIOSIDASE 1 (Homo sapiens)	8 / 11	PHE A  58 GLY A  98 TRP A  99 GLU A 140 MET A 210 ASP A 213 TYR A 267 TRP A 360	None	0.78A	30.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G6M_A_CFFA1_1 (CHITINASE)	1wb0	CHITOTRIOSIDASE 1 (Homo sapiens)	8 / 11	TYR A  27 PHE A  58 GLY A  98 ASP A 138 MET A 210 TYR A 212 TYR A 267 TRP A 360	None	0.94A	30.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G6M_A_CFFA1_1 (CHITINASE)	1wb0	CHITOTRIOSIDASE 1 (Homo sapiens)	9 / 11	TYR A  27 PHE A  58 GLY A  98 GLU A 140 MET A 210 TYR A 212 ASP A 213 TYR A 267 TRP A 360	None	0.64A	30.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G6M_A_CFFA1_1 (CHITINASE)	2ybu	ACIDIC MAMMALIAN CHITINASE (Homo sapiens)	9 / 11	PHE A  58 GLY A  98 TRP A  99 GLU A 140 MET A 210 TYR A 212 ASP A 213 TYR A 267 TRP A 360	CX9  A1398 (-4.5A) CX9  A1398 (-3.5A) CX9  A1399 ( 3.4A) CX9  A1398 (-3.7A) CX9  A1398 (-3.3A) CX9  A1398 (-4.3A) CX9  A1398 ( 4.4A) None CX9  A1398 ( 3.3A)	0.63A	30.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G6M_A_CFFA1_1 (CHITINASE)	2ybu	ACIDIC MAMMALIAN CHITINASE (Homo sapiens)	6 / 11	TYR A  27 PHE A  58 GLY A  98 ASP A 138 TYR A 212 TYR A 267	None CX9  A1398 (-4.5A) CX9  A1398 (-3.5A) CX9  A1398 (-3.0A) CX9  A1398 (-4.3A) None	1.00A	30.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G6M_A_CFFA1_1 (CHITINASE)	2ybu	ACIDIC MAMMALIAN CHITINASE (Homo sapiens)	9 / 11	TYR A  27 PHE A  58 GLY A  98 GLU A 140 MET A 210 TYR A 212 ASP A 213 TYR A 267 TRP A 360	None CX9  A1398 (-4.5A) CX9  A1398 (-3.5A) CX9  A1398 (-3.7A) CX9  A1398 (-3.3A) CX9  A1398 (-4.3A) CX9  A1398 ( 4.4A) None CX9  A1398 ( 3.3A)	0.59A	30.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G6M_A_CFFA1_1 (CHITINASE)	3bxw	CHITINASE DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	6 / 11	TYR B  62 GLU B 170 MET B 237 TYR B 239 TYR B 280 TRP B 358	None	0.99A	23.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G6M_A_CFFA1_1 (CHITINASE)	4ay1	CHITINASE-3-LIKE PROTEIN 2 (Homo sapiens)	6 / 11	TYR A  32 PHE A  63 GLY A 103 ASP A 213 TYR A 269 TRP A 360	NAG  A 401 (-3.9A) None NAG  A 401 (-3.5A) NAG  A 401 (-2.8A) NAG  A 400 (-3.7A) NAG  A 401 (-3.7A)	0.80A	27.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G6M_A_CFFA427_1 (CHITINASE)	1hjv	CHITINASE-3 LIKE PROTEIN 1 (Homo sapiens)	4 / 5	TRP A  99 TYR A 141 MET A 204 ASP A 207	NAG  A   1 (-3.6A) NAG  A   1 (-4.9A) NAG  A   1 (-3.7A) NAG  A  -1 (-3.7A)	0.74A	30.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G6M_A_CFFA427_1 (CHITINASE)	1hkk	CHITOTRIOSIDASE-1 (Homo sapiens)	5 / 5	TRP A  99 TYR A 141 MET A 210 ASP A 213 TRP A 218	NAA  A1390 ( 4.3A) NAA  A1390 (-4.5A) AMI  A1388 (-3.3A) AMI  A1388 ( 2.9A) NAA  A1390 (-3.2A)	0.84A	33.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G6M_A_CFFA427_1 (CHITINASE)	1wb0	CHITOTRIOSIDASE 1 (Homo sapiens)	4 / 5	TRP A  99 TYR A 141 MET A 210 ASP A 213	None	0.91A	30.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G6M_A_CFFA427_1 (CHITINASE)	1wb0	CHITOTRIOSIDASE 1 (Homo sapiens)	4 / 5	TYR A 141 MET A 210 ASP A 213 TRP A 218	None	0.55A	30.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G6M_A_CFFA427_1 (CHITINASE)	2ybu	ACIDIC MAMMALIAN CHITINASE (Homo sapiens)	5 / 5	TRP A  99 TYR A 141 MET A 210 ASP A 213 TRP A 218	CX9  A1399 ( 3.4A) None CX9  A1398 (-3.3A) CX9  A1398 ( 4.4A) CX9  A1399 (-3.3A)	0.73A	30.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	1vd2	PROTEIN KINASE C, IOTA TYPE (Homo sapiens)	4 / 7	VAL A  19 MET A  59 LEU A  77 ILE A  36	None	0.89A	15.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	2b4x	ANTITHROMBIN-III (Homo sapiens)	4 / 7	VAL I 165 LEU I  51 ASN I  55 ILE I 119	None	1.02A	20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	2ibu	ACETYL-COA ACETYLTRANSFERASE (Homo sapiens)	4 / 7	PHE A 315 MET A 141 LEU A 295 ILE A 133	None	1.02A	23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	2qp4	BILE SALT SULFOTRANSFERASE (Homo sapiens)	4 / 7	PHE A 109 MET A 173 LEU A  40 ILE A  38	None	0.72A	17.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	2rvj	EPITHELIAL SPLICING REGULATORY PROTEIN 1 (Homo sapiens)	4 / 7	VAL A 520 MET A 513 LEU A 465 ILE A 493	None	0.90A	15.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	3qak	ADENOSINE RECEPTOR A2A,LYSOZYME CHIMERA (Escherichia virus T4; Homo sapiens)	6 / 7	VAL A  84 PHE A 168 MET A 177 LEU A 249 ASN A 253 ILE A 274	None UKA  A1200 (-3.4A) UKA  A1200 (-4.8A) UKA  A1200 (-4.9A) UKA  A1200 (-3.4A) UKA  A1200 (-4.9A)	1.00A	65.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	4at3	BDNF/NT-3 GROWTH FACTORS RECEPTOR (Homo sapiens)	4 / 7	VAL A 706 LEU A 645 ASN A 642 ILE A 762	None	1.01A	19.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	5g53	ADENOSINE RECEPTOR A2A (Homo sapiens)	5 / 7	MET A 174 LEU A 249 ASN A 253 MET A 270 ILE A 274	NEC  A 400 ( 4.8A) NEC  A 400 ( 4.6A) NEC  A 400 (-3.3A) None NEC  A 400 (-4.6A)	1.44A	91.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	5g53	ADENOSINE RECEPTOR A2A (Homo sapiens)	6 / 7	VAL A  84 PHE A 168 MET A 177 LEU A 249 ASN A 253 ILE A 274	None NEC  A 400 (-3.6A) NEC  A 400 (-4.8A) NEC  A 400 ( 4.6A) NEC  A 400 (-3.3A) NEC  A 400 (-4.6A)	1.04A	91.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	5lzk	PROTEIN FAM83B (Homo sapiens)	4 / 7	VAL A 199 MET A 191 LEU A 180 ILE A 178	None	1.03A	20.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	5n2s	SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A1 (Escherichia coli; Homo sapiens)	5 / 7	VAL A1192 PHE A1276 LEU A1355 ASN A1359 ILE A1379	8K8  A2001 ( 4.1A) 8K8  A2001 ( 3.4A) 8K8  A2001 ( 4.3A) 8K8  A2001 ( 3.1A) 8K8  A2001 ( 4.2A)	0.87A	45.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	5n2s	SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A1 (Escherichia coli; Homo sapiens)	5 / 7	VAL A1192 PHE A1276 MET A1285 LEU A1355 ASN A1359	8K8  A2001 ( 4.1A) 8K8  A2001 ( 3.4A) 8K8  A2001 ( 4.5A) 8K8  A2001 ( 4.3A) 8K8  A2001 ( 3.1A)	0.89A	45.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	5nug	CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1 (Homo sapiens)	4 / 7	MET A2755 LEU A2769 ASN A2752 MET A2773	None	0.67A	5.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	5uen	ADENOSINE RECEPTOR A1,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A1 (Escherichia coli; Homo sapiens)	6 / 7	VAL A  87 PHE A 171 MET A 180 LEU A 250 ASN A 254 ILE A 274	DU1  A1201 (-4.7A) DU1  A1201 (-3.5A) DU1  A1201 (-3.4A) DU1  A1201 (-4.4A) DU1  A1201 (-3.1A) DU1  A1201 (-4.3A)	0.94A	40.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	5v57	SMOOTHENED HOMOLOG,FLAVODOXIN,S MOOTHENED HOMOLOG (Desulfovibrio vulgaris; Homo sapiens)	4 / 7	VAL A 321 LEU A 522 MET A 230 ILE A 234	None 836  A1201 (-4.6A) 836  A1201 (-3.5A) None	0.87A	21.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	6aqf	ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A (Escherichia coli; Homo sapiens)	5 / 7	PHE A 168 LEU A 249 ASN A 253 MET A 270 ILE A 274	ZMA  A1201 (-3.5A) ZMA  A1201 (-4.1A) ZMA  A1201 (-3.2A) ZMA  A1201 (-4.8A) ZMA  A1201 (-4.8A)	0.69A	86.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	6aqf	ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A (Escherichia coli; Homo sapiens)	6 / 7	VAL A  84 PHE A 168 MET A 177 LEU A 249 ASN A 253 ILE A 274	None ZMA  A1201 (-3.5A) None ZMA  A1201 (-4.1A) ZMA  A1201 (-3.2A) ZMA  A1201 (-4.8A)	0.62A	86.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	6d9h	CHIMERA PROTEIN OF MUSCARINIC ACETYLCHOLINE RECEPTOR M4 AND ADENOSINE RECEPTOR A1 (Homo sapiens)	6 / 7	VAL R  87 PHE R 171 MET R 180 LEU R 250 ASN R 254 ILE R 274	ADN  R 400 (-4.8A) ADN  R 400 (-3.8A) ADN  R 400 (-4.6A) ADN  R 400 (-4.5A) ADN  R 400 (-2.9A) ADN  R 400 ( 4.9A)	1.04A	15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	6gdg	TRXA,ADENOSINE RECEPTOR A2A (Escherichia coli; Homo sapiens)	5 / 7	MET A 174 LEU A 249 ASN A 253 MET A 270 ILE A 274	NEC  A 400 ( 4.7A) NEC  A 400 (-4.9A) NEC  A 400 (-3.5A) None NEC  A 400 (-4.2A)	1.40A	13.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RFM_A_CFFA330_1 (ADENOSINE RECEPTOR A2A)	6gdg	TRXA,ADENOSINE RECEPTOR A2A (Escherichia coli; Homo sapiens)	4 / 7	MET A 177 LEU A 249 ASN A 253 ILE A 274	NEC  A 400 (-4.3A) NEC  A 400 (-4.9A) NEC  A 400 (-3.5A) NEC  A 400 (-4.2A)	0.65A	13.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y4D_A_CFFA411_1 (ENDOTHIAPEPSIN)	1wyo	MICROTUBULE-ASSOCIAT ED PROTEIN RP/EB FAMILY MEMBER 3 (Homo sapiens)	4 / 6	LEU A  58 PHE A 122 ILE A 115 PHE A 118	None	1.13A	21.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y4D_A_CFFA411_1 (ENDOTHIAPEPSIN)	1ya0	SMG-7 TRANSCRIPT VARIANT 2 (Homo sapiens)	4 / 6	LEU A 272 LEU A 334 ILE A 254 PHE A 253	None	0.97A	20.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y4D_A_CFFA411_1 (ENDOTHIAPEPSIN)	2d5r	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 7 (Homo sapiens)	4 / 6	ASP A  70 LEU A  65 ILE A 184 PHE A 181	None	1.06A	19.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y4D_A_CFFA411_1 (ENDOTHIAPEPSIN)	2jak	SERINE/THREONINE-PRO TEIN PHOSPHATASE 2A 56 KDA REGULATORY SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 6	LEU A 224 LEU A 254 PHE A 208 PHE A 211	None	1.06A	21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y4D_A_CFFA411_1 (ENDOTHIAPEPSIN)	3nh9	ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 6, MITOCHONDRIAL (Homo sapiens)	4 / 6	LEU A 795 LEU A 606 ILE A 590 PHE A 592	None	1.16A	22.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y4D_A_CFFA411_1 (ENDOTHIAPEPSIN)	4gmj	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 7 (Homo sapiens)	4 / 6	ASP B  70 LEU B  65 ILE B 184 PHE B 181	None	0.95A	18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y4D_A_CFFA411_1 (ENDOTHIAPEPSIN)	5e26	PANTOTHENATE KINASE 2, MITOCHONDRIAL (Homo sapiens)	4 / 6	LEU A 524 LEU A 435 ILE A 497 PHE A 418	None	1.04A	22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y4D_A_CFFA411_1 (ENDOTHIAPEPSIN)	5h64	SERINE/THREONINE-PRO TEIN KINASE MTOR (Homo sapiens)	4 / 6	LEU A1142 ASP A1147 LEU A1115 ILE A1156	None	1.20A	8.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y4D_A_CFFA411_1 (ENDOTHIAPEPSIN)	5hcc	COMPLEMENT C5 (Homo sapiens)	4 / 6	ASP A1330 LEU A 982 PHE A1333 ILE A1313	None	1.17A	16.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y4D_A_CFFA411_1 (ENDOTHIAPEPSIN)	5tfm	CADHERIN-23 (Homo sapiens)	4 / 6	LEU A 817 LEU A 829 PHE A 800 ILE A 810	None	1.19A	14.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y4D_A_CFFA411_1 (ENDOTHIAPEPSIN)	5y3r	X-RAY REPAIR CROSS-COMPLEMENTING PROTEIN 6 (Homo sapiens)	4 / 6	LEU A  38 ASP A  81 LEU A 108 ILE A  67	None	1.13A	18.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y4D_A_CFFA411_1 (ENDOTHIAPEPSIN)	6bfn	INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 1 (Homo sapiens)	4 / 6	LEU A 501 LEU A 496 ILE A 341 PHE A 410	None	1.25A	15.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y4D_A_CFFA411_1 (ENDOTHIAPEPSIN)	6d9h	CHIMERA PROTEIN OF MUSCARINIC ACETYLCHOLINE RECEPTOR M4 AND ADENOSINE RECEPTOR A1 (Homo sapiens)	4 / 6	LEU R  29 PHE R 299 ILE R 292 PHE R 295	None	0.93A	13.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y4D_A_CFFA411_1 (ENDOTHIAPEPSIN)	6fra	HUMAN T-CELL RECEPTOR F11 ALPHA CHAIN (Homo sapiens)	4 / 6	LEU A  44 PHE A  90 ILE A 101 PHE A 102	EDO  A 304 (-4.9A) None None EDO  A 306 ( 4.1A)	1.26A	14.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MZP_A_CFFA2401_1 (ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A)	2qp4	BILE SALT SULFOTRANSFERASE (Homo sapiens)	5 / 9	ILE A  32 PHE A 109 MET A 173 LEU A  40 ILE A  38	None	1.12A	19.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MZP_A_CFFA2401_1 (ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A)	3gd7	FUSION COMPLEX OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, RESIDUES 1193-1427 AND MALTOSE/MALTODEXTRIN IMPORT ATP-BINDING PROTEIN MALK, RESIDUES 219-371 (Escherichia coli; Homo sapiens)	5 / 9	ILE A1554 VAL A1507 MET A1469 LEU A1451 ILE A1494	None	1.41A	21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MZP_A_CFFA2401_1 (ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A)	3gd7	FUSION COMPLEX OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, RESIDUES 1193-1427 AND MALTOSE/MALTODEXTRIN IMPORT ATP-BINDING PROTEIN MALK, RESIDUES 219-371 (Escherichia coli; Homo sapiens)	5 / 9	ILE A1554 VAL A1507 MET A1469 LEU A1492 ILE A1494	None	1.15A	21.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5MZP_A_CFFA2401_1 (ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A)	3qak	ADENOSINE RECEPTOR A2A,LYSOZYME CHIMERA (Escherichia virus T4; Homo sapiens)	6 / 9	ILE A  66 PHE A 168 MET A 177 LEU A 249 ASN A 253 ILE A 274	UKA  A1200 (-4.1A) UKA  A1200 (-3.4A) UKA  A1200 (-4.8A) UKA  A1200 (-4.9A) UKA  A1200 (-3.4A) UKA  A1200 (-4.9A)	0.46A	69.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5MZP_A_CFFA2401_1 (ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A)	3qak	ADENOSINE RECEPTOR A2A,LYSOZYME CHIMERA (Escherichia virus T4; Homo sapiens)	6 / 9	VAL A  84 PHE A 168 MET A 177 LEU A 249 ASN A 253 ILE A 274	None UKA  A1200 (-3.4A) UKA  A1200 (-4.8A) UKA  A1200 (-4.9A) UKA  A1200 (-3.4A) UKA  A1200 (-4.9A)	0.86A	69.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5MZP_A_CFFA2401_1 (ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A)	5g53	ADENOSINE RECEPTOR A2A (Homo sapiens)	8 / 9	ILE A  66 PHE A 168 GLU A 169 MET A 177 LEU A 249 ASN A 253 MET A 270 ILE A 274	None NEC  A 400 (-3.6A) NEC  A 400 (-4.0A) NEC  A 400 (-4.8A) NEC  A 400 ( 4.6A) NEC  A 400 (-3.3A) None NEC  A 400 (-4.6A)	0.48A	70.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5MZP_A_CFFA2401_1 (ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A)	5g53	ADENOSINE RECEPTOR A2A (Homo sapiens)	8 / 9	VAL A  84 PHE A 168 GLU A 169 MET A 177 LEU A 249 ASN A 253 MET A 270 ILE A 274	None NEC  A 400 (-3.6A) NEC  A 400 (-4.0A) NEC  A 400 (-4.8A) NEC  A 400 ( 4.6A) NEC  A 400 (-3.3A) None NEC  A 400 (-4.6A)	0.82A	70.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5MZP_A_CFFA2401_1 (ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A)	5n2s	SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A1 (Escherichia coli; Homo sapiens)	7 / 9	ILE A1174 VAL A1192 PHE A1276 MET A1285 LEU A1355 ASN A1359 ILE A1379	8K8  A2001 ( 4.0A) 8K8  A2001 ( 4.1A) 8K8  A2001 ( 3.4A) 8K8  A2001 ( 4.5A) 8K8  A2001 ( 4.3A) 8K8  A2001 ( 3.1A) 8K8  A2001 ( 4.2A)	0.73A	37.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5MZP_A_CFFA2401_1 (ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A)	5uen	ADENOSINE RECEPTOR A1,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A1 (Escherichia coli; Homo sapiens)	6 / 9	VAL A  87 PHE A 171 MET A 180 LEU A 250 ASN A 254 ILE A 274	DU1  A1201 (-4.7A) DU1  A1201 (-3.5A) DU1  A1201 (-3.4A) DU1  A1201 (-4.4A) DU1  A1201 (-3.1A) DU1  A1201 (-4.3A)	0.58A	64.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5MZP_A_CFFA2401_1 (ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A)	6aqf	ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A (Escherichia coli; Homo sapiens)	9 / 9	ILE A  66 VAL A  84 PHE A 168 GLU A 169 MET A 177 LEU A 249 ASN A 253 MET A 270 ILE A 274	None None ZMA  A1201 (-3.5A) ZMA  A1201 (-4.1A) None ZMA  A1201 (-4.1A) ZMA  A1201 (-3.2A) ZMA  A1201 (-4.8A) ZMA  A1201 (-4.8A)	0.32A	98.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MZP_A_CFFA2401_1 (ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A)	6d9h	CHIMERA PROTEIN OF MUSCARINIC ACETYLCHOLINE RECEPTOR M4 AND ADENOSINE RECEPTOR A1 (Homo sapiens)	7 / 9	ILE R  69 VAL R  87 PHE R 171 MET R 180 LEU R 250 ASN R 254 ILE R 274	None ADN  R 400 (-4.8A) ADN  R 400 (-3.8A) ADN  R 400 (-4.6A) ADN  R 400 (-4.5A) ADN  R 400 (-2.9A) ADN  R 400 ( 4.9A)	0.97A	11.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MZP_A_CFFA2401_1 (ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A)	6d9h	CHIMERA PROTEIN OF MUSCARINIC ACETYLCHOLINE RECEPTOR M4 AND ADENOSINE RECEPTOR A1 (Homo sapiens)	5 / 9	PHE R 171 GLU R 172 MET R 180 LEU R 250 ASN R 254	ADN  R 400 (-3.8A) ADN  R 400 (-3.5A) ADN  R 400 (-4.6A) ADN  R 400 (-4.5A) ADN  R 400 (-2.9A)	1.02A	11.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MZP_A_CFFA2401_1 (ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A)	6gdg	TRXA,ADENOSINE RECEPTOR A2A (Escherichia coli; Homo sapiens)	6 / 9	ILE A  66 MET A 177 LEU A 249 ASN A 253 MET A 270 ILE A 274	None NEC  A 400 (-4.3A) NEC  A 400 (-4.9A) NEC  A 400 (-3.5A) None NEC  A 400 (-4.2A)	0.41A	12.87